The gastrointestinal tract allows the residence of an almost enumerable number of bacteria. To maintain homeostasis, the mucosal immune system must remain tolerant to the commensal microbiota and eradicate pathogenic bacteria. 
INTRODUCTION
The main function of the intestine is digestion and absorption of nutrients from food and recovery of water and electrolytes. In addition, the intestine houses a large immune compartment, as it is responsible for prevention and control of mucosal infections, regulation of microbial colonization, and induction of oral tolerance. Impaired or uncontrolled mucosal immune responses toward commensal or pathogenic bacteria may result in infections and are implicated in the pathogenesis of autoimmune diseases, such as inflammatory bowel disease (IBD).
Natural killer T cells (NKT cells) represent a minor subset of T lymphocytes that share cell-surface proteins with conventional T cells and NK cells. 1 These cells are located mainly in the liver, spleen, and bone marrow and depend on the thymus for their development, similar to conventional T cells. Many NKT cells express a T-cell receptor (TCR) that recognizes lipid antigens presented by the non-classical major histocompatibility complex (MHC) class I molecule CD1d. In the intestine, variant and invariant NKT (iNKT) cells are found among intraepithelial lymphocytes (IELs) and within the lamina propria (LP).
The activation of intestinal NKT cells by CD1d-expressing antigen-presenting cells (APCs) may contribute to mucosal immunity directed against pathogenic or commensal bacteria. On the other hand, uncontrolled or insufficient activation of NKT cells may have an important role in the pathogenesis of IBD.
With reference to recent literature on the role of iNKT cells in mucosal immunology, 2 -4 this review will mainly focus on the role of other intestinal NKT cells (e.g., mucosal (m) NKT cells and NKT cells) in mucosal immunity and the interaction of NKT cells with other immune cells such as dendritic cells (DCs) and B lymphocytes.
NKT cell nomenclature
NKT cells were originally defined by the co-expression of a conventional TCR and NK receptors such as NK1.1 in certain mouse strains and CD161 in humans. Similar to NK cells, these cells contain perforin and granzymes, enabling them to take part in innate immune responses. 1, 5, 6 Unlike conventional T cells that recognize peptides bound to MHC class I or II molecules, NKT cells recognize glycolipid structures that are presented by CD1d. Most NKT cells express an invariant TCR, as it consists of invariant -chains combined with a restricted subset of -chains. Ligation of the NKT-cellspecific TCR leads to rapid secretion of cytokines, including interferon-(IFN-), interleukin-4 (IL-4), and various chemokines. 1 Expanding knowledge on the properties of NKT cells gave rise to a new classification according to the (in)-variance of the involved TCR -chain, the selecting antigen-presenting molecule, and the expression of various cell surface molecules. 3 There are so-called canonical or type I NKT cells, including both iNKT and mNKT (or mucosal-associated invariant REVIEW T cells (MAIT cells)) cells, which express TCRs with invariant V chains. 3 The TCR of the iNKT cell population in mice contains the V 14 gene segment, whereas its human counterpart uses V 24. Type I iNKT cells can be identified by using -galactosylceramide ( GalCer) / CD1d tetramers. 7, 8 The mNKT population uses the V 7.2 gene segment in mice and V 19 in humans. 9 Several mouse models have been developed for studying NKT cells and related antigen-presenting molecules ( Table 1 ). The generation of knockout mice and transgenic mice with overexpression of invariant TCRs by iNKT or mNKT cells has greatly facilitated the functional analyses of these cells.
Another CD1d-restricted NKT cell population, known as variant or type II NKT cells, has a variant TCR rearrangement and has been identified in both mice and humans. 10,11 A major type II NKT subset recognizes the self-glycolipid 3-sulfated galactosylceramide, known as sulfatide, and can be identified by sulfatide / CD1d tetramers. 11 Although type II NKT cells have not been studied as extensively as type I NKT cells, these cells have been implicated in a number of autoimmune diseases. Interestingly, high IL-13 secretion by type II NKT cells has been suggested in the pathogenesis of ulcerative colitis. 12 Recently, it was found that sulfatide-reactive type II NKT cells are able to regulate type I NKT cells by modulating DC function. 13, 14 A small group of T cells co-expressing NK markers are the so-called NKT cells, which express a TCR instead of an TCR. 15 
NKT cell differentiation
Similar to conventional T cells, iNKT cells develop in the thymus and branch off at the double-positive (DP) stage. In the thymus, DP cells develop into CD4 + , CD8 + , or NKT cells by positive selection that is mediated by MHC-I, MHC-II, or CD1d molecules, respectively. The NKT cell developmental pathway starts with positive selection when a DP precursor expresses a correctly rearranged TCR and interacts with other DP thymocytes expressing a CD1d molecule, presumably presenting self-glycolipids. After positive selection, iNKT cells leave the thymus at an immature stage as defined by the absence of NK receptor expression, for example, NK1.1, and undergo terminal maturation in the periphery. 16 For iNKT as well as mNKT cells, it is currently unknown what signals regulate this final differentiation. Several proteins and transcription factors have been shown to be essential for the development of murine iNKT cells, including the adaptor SLAM-associated protein (SAP), calcineurin, and the transcription factors c-Myc, early growth factor 2 (Egr2), and promyelocytic leukemia zinc-finger (PLZF). 17 -21 Furthermore, iNKT cell differentiation has recently been shown to be regulated by transforming growth factor (TGF-) and Wiskott -Aldrich syndrome protein signaling. 22, 23 It can be noted that mNKT cells were detected in normal numbers and phenotype in the blood of five SAP-deficient patients, 24 suggesting that SAP-mediated signal transduction is not involved in human mNKT cell development.
The role of PLZF in mNKT cell development is more complicated as PLZF is not expressed in murine mNKT cells, but can be found in high levels in human blood mNKT cells. 24 This could be explained by the fact that PLZF was found to induce a transcriptional program in mice that leads to the generation of CD4 + T cells with a memory phenotype, 25 corresponding with the naive phenotype of murine mNKT cells and the antigen-experienced phenotype of human mNKT cells in peripheral blood. 24 These data suggest that differentiation of the various NKT cell subsets is regulated by distinct mechanisms and emphasizes discrepancies between murine and human NKT cell differentiation. Future studies are necessary to delineate the role of these factors for the differentiation and development of human NKT cell populations as well as murine NKT cell populations, other than iNKT cells.
NKT cell location
Several reports indicate the presence of different NKT cell populations in the intestines of both mice and humans. However, in part due to the inconsistent use of definitions for NKT cells, there is a great variation among the different studies regarding the exact numbers of these cells. Furthermore, conventional T cells have been found to upregulate NK markers upon activation such as NK1.1, making the distinction between NKT and activated conventional T cells even more complicated. 6 
REVIEW
In mice, NKT cells are found at the highest frequency in the liver (10 -40 % of liver lymphocytes) and in lower frequencies ( < 1 % ) in the thymus, bone marrow, spleen, lymph nodes, and blood. 26 In the murine intestine, 4 -10 % of the IELs within small or large intestine and LP lymphocytes (LPLs) were shown to co-express TCR -CD3 complexes and NK cell receptors. 27, 28 Most of these cells were CD8 + and a large proportion of these cells were identified as T cells. 28 It can be noted that CD3 / NK1.1 + cells may still be present within the intestinal tissues in the absence of CD1d. 27, 28 In humans, NKT cells were found in the same organs; however, the calculated frequencies were lower compared with mice. 26 In the human intestine, it was estimated that < 0.4 % of all T cells were iNKT cells and are mainly localized within the LP based on expression of the invariant TCR. With the development of tetrameric complexes of GalCer-loaded CD1d molecules, iNKT cells are relatively easily studied in mice and humans. 7, 8 To date, however, the physiological localization of NKT cell subsets within tissues is still largely unclear due to the lack of antibodies that work efficiently for immunohistochemical analysis of intestinal tissue.
It has been established that mNKT cells in both humans and mice primarily accumulate in the intestinal LP. Furthermore, human mNKT cells represent up to 1 -4 % of total peripheral blood T cells, a much higher number compared with the reported frequency of ~ 0.2 % of human iNKT cells in peripheral blood. 24, 31 Presumably, the newly synthesized anti-V 7.2 monoclonal antibody will provide more detailed information on the location and frequency of human mNKT cells. 24 
Intestinal mNKT cells
Similar to iNKT cells, mNKT cells are characterized by the expression of a semi-invariant TCR, consisting of V 7.2 -J 33 in humans and V 19 -J 33 in mice, combined with a limited number of V -chains (V 2 and V 13 in humans, and V 6 and V 8 in mice). These TCRs recognize glycolipids presented by the MHC-related molecule 1 or MR1, an MHC class I-like molecule that is highly conserved in mammals. 9 At present, the nature of the antigens presented by MR1 remains unknown. 32 The development of mNKT cells is dependent on the presence of commensal microbiota and on the expression of MR1 by bone marrow-derived cells. As mNKT cells were found to specifically accumulate in the LP of the intestine, this suggests that these cells may, in fact, be directed to microbial antigens presented by MR1 molecules. 9 mNKT cells have been detected in the human thymus and in mouse fetal thymic organ cultures. 24 As these cells were absent in nude mice, it is likely that mNKT cells develop in the thymus, similar to other NKT cell subsets and conventional T cells. 33 Furthermore, it was found in mice that B cells are not required for thymic development of mNKT cells, but can however promote the expansion of these cells in the periphery. Interestingly, MR1-deficient B cells were found to be almost as efficient in inducing mNKT cell expansion as MR1-proficient cells, suggesting that cognate interactions between the invariant TCR and MR1 might not be necessary for this expansion. 24 In mice, as well as in human cord blood, mNKT cells show a naive phenotype, as they lack expression of antigen-experienced markers, such as NK1.1, CD25, CD69, or ICOS. 24 In contrast, mTCR transgenic mice 34, 35 and human adult mNKT cells express markers that are associated with a memory phenotype. 24 Finally, murine mNKT cells have been shown to express the chemokine receptor CXCR6 and integrin 4 7, which are required for gut homing. 24 
Intestinal ␥ ␦ NKT cells
The T cells are a highly conserved subset of T cells in mice, which constitute 1 -5 % of the blood or peripheral organ lymphocytes, but can account for up to 50 % of the lymphocytes that are present within the mucosal epithelia. 36 These cells express memory cell-surface markers and are capable of rapid secretion of effector cytokines.
Recently, it was found that murine T cell differentiation and effector functions are regulated by the TCR signaling molecule Itk, a Tec family tyrosine kinase. 37 Itk has been shown earlier to suppress the development of innate T cells and to promote the development of conventional T cells. 38 Interestingly, Itk − / − mice harbor increased numbers of CD4 + NK1.1 + T cells, known as NKT cells, which also express PLZF, the transcription factor essential for NKT development. 18, 19, 37 These Itk − / − NKT cells were found to produce high levels of IL-4, IL-10, and IL-13 in addition to IFN-and expressed B-cell co-stimulatory molecules, such as ICOS, CD40L, and OX40, suggesting a role for these cells in Bcell activation and IgE class switching. 37 These findings suggest that Itk regulates the lineage development and effector function of murine NKT cells.
In the murine intestine, it was found that upon induction of colitis with dextran sulfate sodium, colonic IELs that bear TCRs ( IEL) induce a transcriptional program that includes protection of epithelial cells, antibacterial defense, and inflammatory cell recruitment. 39 These IELs were found to be essential for controlling bacterial penetration across injured mucosal surfaces. Intestinal microbes were required for enhanced expression of both the antibacterial factor RegIII and several chemotactic cytokines that function in inflammatory cell recruitment. Moreover, the IEL injury responses that were abrogated in germ-free mice could be restored with the conventional microbiota, suggesting that IELs need an appropriate bacterial signal to respond. 39 In another study, it was shown that T cells can act as regulatory cells that are anergic in vitro , but can suppress conventional T-cell proliferation and ameliorate 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis in vivo by the production of TGF-and IL-10. 40 These findings provide new insights into the role of T cells in maintaining intestinal tissue homeostasis.
As NKT cells are part of the T cell subset, and not all studies have included the analysis of NKT cell markers, findings on the role of T cells in mucosal immunity may also implicate a role for NKT cells.
REVIEW

CD1d expression in the intestine
CD1d is a MHC class I-related molecule that consists of a light chain ( 2-microglobulin) that is non-covalently associated with a heavy chain. 41 Furthermore, CD1d is structurally related to HLA-A, HLA-B, and HLA-C proteins. 5 CD1d is expressed by professional APCs, such as dendritic cells, macrophages, and B cells, and non-professional APCs such as hepatocytes and intestinal epithelial cells (IECs) ( Figure 1 and refs. 42 -44 ). CD1d molecules are essentially non-polymorphic, suggesting that these molecules can present only a limited set of (glycolipid) antigens. There is a high degree of conservation of the canonical TCRs and CD1d molecules that allow interspecies cross-reactivity, indicating that these cells have a central role in immunity.
IECs have been found to be capable of presenting antigen to both conventional and NKT cells within the pool of intestinal lymphocytes. Moreover, human IEC were found to be able to activate NKT cells in vitro in a CD1d-dependent manner, 45, 46 suggesting that CD1d expression by intestinal cells may serve as a target for NKT cells, contributing to the chronic phase of intestinal inflammation ( Figure 1 and refs. 47,48 ).
Next to a role in antigen presentation, CD1d was also shown to be capable of cellular activation in the absence of NKT cells. In particular, ligation of CD1d on IECs gave rise to retrograde epithelial signaling and IL-10 production. 49 The latter mechanism may thus contribute to tissue homeostasis and control of inflammation at the mucosal surfaces.
NKT cell ligands
The knowledge on the nature of ligands presented by MR1-restricted or CD1d-restricted NKT cells in vivo remains limited. 50 The most efficient compound that activates classical iNKT cells is a synthetic glycolipid, originally derived from a marine sponge, known as GalCer. 51 This molecule binds efficiently to CD1d, and the CD1d: GalCer complex binds the iNKT TCR, 51, 52 leading to the activation of these cells in both mice and humans. 53 Several studies have shown that GalCer is a very potent NKT cell agonist. 51, 52 It has been shown that iNKT cells can respond to glycosphingolipids derived from the cell walls of Gram-negative Sphingomonas spp ., 54 -56 -galactosyl diacylglycerols from Borrelia burgdorferi , 57 and phosphatidylinositol mannoside from mycobacteria. 58 Recently, the endogenous lysosomal lipid isoglobotrihexosylceramide was shown to potently activate both mouse and human NKT cells, and was proposed as an endogenous ligand for iNKT cells. 59 To date, these findings have found insufficient support 60, 61 that leaves open the quest for the endogenous antigens for iNKT cells. 62 The activation of human APCs by Toll-like receptor (TLR) ligands modulates the lipid biosynthetic pathway, resulting in enhanced recognition of CD1d-associated lipids by NKT cells and increased IFN-production. 63 Together with the identification of functional TLRs on NKT cells, 64 these results suggest that NKT cells may be regarded as key players in microbial sensing and the orchestration of ensuing mucosal immune responses ( Figure 2 ). mNKT cells have been shown to be stimulated by the glycolipid -mannosylceramide ( ManCer). 65 To date, these findings have not been confirmed and the structure of MR1 does not appear to be suitable for lipid binding. 66 Intriguingly, ManCer has been used as a negative lipid control for iNKT activation by GalCer 67, 68 or even as a CD1d glycolipid antagonist. 69 Specific ligands for NKT have not been described yet.
NKT cell effector functions
NKT cells can mediate potent immune regulatory functions in autoimmunity, cancer, infection, and tolerance. 70 The biological function of NKT cells is paradoxical, because these cells can rapidly produce large amounts of T-helper type 1 (Th1), Th2, and regulatory cytokines. NKT cells may thus promote or suppress cell-mediated immunity in different conditions. 70 It has been suggested that these diverse functions of NKT cells are regulated by functionally distinct NKT cell subsets, broadly divided into CD4 + and CD4 − NKT cells. 6 Mouse CD4 + and CD4 − NKT cells are distinct in their ability to regulate immune responses in vivo. However, there is no clear distinction in their ability to produce different cytokines. 71 Mouse NKT cells have been recognized as immunosuppressive cells that produce Th2 
REVIEW
cytokines or IL-10, whereas in other conditions these cells appear to promote enhanced cell-mediated immunity through the production of Th1 cytokines. 72, 73 It was shown that human CD4 + NKT cells can produce both Th1 and Th2 cytokines, whereas CD4 − NKT cells primarily produce only Th1 cytokines. 74 In the human colon and duodenum, most of the NKT cells are CD161 + , and these cells account for about half of all T cells in both the epithelial layer and the LP. Almost all of the CD161 + T cells express an TCR and are able to express both CD4 + or CD8 + cells, but the majority of the cells within the IEL compartment is CD8 + , whereas CD4 + cells predominate the LPL population. 30 Regarding the function of mNKT cells, many questions are still unanswered. So far, murine mNKT cells have been shown to rapidly produce effector cytokines, including IL-4, IL-5, IL-10, TNF , and IFN-upon activation through MR1. 34, 35 The mNKT cell-specific anti-V 7.2 antibody will enable further functional analysis of these cells in humans. 24
IL17-and IL22-producing NKT cells in the intestine
It has been shown that, similar to Th17 cells, 75 NKT cells can express the pro-inflammatory cytokines IL-17 and IL-22. 76, 77 The IL17-producing NKT cells were NK1.1 − DX5 + TCR + and shown to constitutively express IL-23R and the ROR t transcription factor. 78, 79 The production of IL-17 by NKT cells may have an important role in the induction of IBD, as increased expression of IL-17 has been reported in both patients with IBD 80, 81 and animal models of this disease ( Figure 3 and refs. 82,83 ). In addition, it was found that polymorphisms in IL-17A and IL-17F genes are associated with increased susceptibility to UC. 84 IL-22, a cytokine of the IL-10 family, is one of the key cytokines that mediates the crosstalk between epithelial cells and immune cells. IL-22 is produced by various leukocytes, including CD4 + and CD8 + T cells, T cells, NK cells, and myeloid cells. 85, 86 Recently, IL-22 has also been shown to be produced by Th17, NK, and, as mentioned, by NKT cells. 75, 76, 87, 88 IL-22 is implicated in the restoration of barrier function upon epithelial damage during inflammation. Furthermore, IL-22 has been found to enhance the production of antimicrobial peptides, proinflammatory cytokines, and chemokines by epithelial cells. 89 -91 The production of IL-17 or IL-22 by subsets of NKT cells may have an important role in physiological processes, such as microbial defense as well as pathological immune responses, which are associated with IBD ( Figure 3 and ref. 92 ).
NKT CELLS IN DISEASE Oral tolerance
In the intestine, DCs continuously take up and transport antigens from the gut lumen to draining lymph nodes, in which they interact with antigen-specific T cells. Under homeostatic conditions, this interaction will result in the unresponsiveness of T cells, thus providing one of the mechanisms for (oral) tolerance 
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toward harmless environmental antigens. Specific activation by additional signals during the interaction of DCs and T cells can block T-cell tolerance induction and instead give rise to inflammatory T-cell responses. 93 NKT cell-deficient mice were shown to have an impaired tolerance induction, suggesting that NKT cells have a critical role in oral tolerance. 94 In these knockout mice, treatment with high-and low-dose ovalbumin failed to induce IL-10 and TGF -producing CD25 + CD4 + regulatory T cells (T reg cells) in Peyer ' s patches and in the spleen. 94 Accordingly, in the presence of NKT cells, DCs were found to produce more IL-10 and lose the ability to produce IL-12, consistent with a tolerogenic DC function. 95 As such, it was proposed that activated NKT cells contribute to the induction of tolerogenic DCs. Furthermore, it was shown that IL-4 and IL-10-producing CD4 + iNKT cells are required for the induction of oral nickel tolerance and for the infectious spread of tolerance from APCs to T reg cells. 96 In contrast to the proposed role for NKT cells in tolerance induction, some studies have shown that NKT cells are not required for induction of oral tolerance. 97 
Injection of
GalCer was shown to activate NKT cells and in turn trigger maturation of splenic DC, thereby blocking the induction of oral tolerance. 98 Along these lines, mucosal administration of GalCer has been proposed as a mucosal adjuvant in two different vaccination studies. 99, 100 Although GalCer may serve as an artificial ligand for mucosal vaccination, the activation of NKT cells by GalCer in vivo may not reflect physiological activation of NKT cells that contributes to tolerance induction.
In conclusion, the role for NKT cells in tolerance induction is still controversial and the outcome may depend on the experimental models applied. 101, 102 NKT cells in IBD Both IECs and DCs functionally express CD1d on the cell surfaces. 5, 46 Oxazolone colitis, a mouse model of human UC, was found to be associated with CD1d-dependent production of Th2 cytokines involved in mucosal inflammation. 67, 103 In particular, CD1d-deficient mice, iNKT cell-deficient mice, and wild type (WT) mice treated with CD1d-blocking antibodies were protected from the development of this colitis. Treatment with an IL-13-decoy receptor prevented tissue inflammation upon intestinal oxazolone exposure, thereby identifying IL-13 as a functionally important and deleterious cytokine in this pathway. 103, 104 This finding correlates with patients with UC, who exhibited increased Th2 cytokine secretion by LP mononuclear cells upon CD1d-NKT cell stimulation. 12 Interestingly, earlier studies in another mouse colitis model suggested that CD1d-restricted NKT cell activation with GalCer could protect from colitis. 105, 106 Therefore, mucosal NKT cells may be involved in both protective and pathogenic immunity. Whether these distinct NKT cell effector functions in colitis are imprinted depending on the specificity of the lipid antigen or whether these NKT cells are regulated within the intestinal tissue remains to be solved. 6,107
NKT cell -DC interactions in the small intestine LP
Several distinct subsets of LP-DCs have been described, 102, 108, 109 of which the CD103 + CD11b + CD8 + subset is able to migrate to the mesenteric lymph node (MLN). 110, 111 It was shown that LP-DCs continuously migrate from the small intestine LP to the MLN in a CCR7-dependent manner. 110, 112 The finding that CCR7 expression by LP-DCs was increased upon GalCer treatment, indicates that NKT activation can promote LP-DCs migration to the MLN. 101 Next to a role in regulation of local DC recruitment, NKT cells can further activate DCs through the production of cytokines such as IFN-. 113, 114 It has become clear that different mucosal subsets of DCs differentially express a range of microbial pattern recognition molecules. 115 There is abundant evidence that iNKT cells can be activated by microbial products such as lipopolysaccharide 55, 64, 116 during antigen presentation. Several findings suggested a positive feedback loop, where lipopolysaccharide activates TLR4-expressing APCs to produce IL-12 and IL-18, which in turn induces early IFN-production by iNKT cells. This IFN-feeds back to the APCs to potentiate TNF production, leading to further APC activation. 113 Alternatively, iNKT cells have been reported to express TLR4 and can thus be directly activated by lipopolysaccharide. 64 TLR or CD14 expression by NKT cells, however, is still debated and therefore needs further confirmation. 113 In summary, some bacteria can activate NKT cells either directly through microbial glycolipid antigens 2,54,117 or indirectly through TLR signaling by APCs and perhaps also NKT cells ( Figure 2 ). Interactions between DCs, NKT cells, and bacteria may therefore crucially contribute to both physiological and pathological immune responses within the intestinal tissue.
NKT cell -B cell interactions in the small intestine
CD1d is detectable on nearly all B cells, and cognate CD1d-dependent interaction with NKT cells can elicit B-cell proliferation and antibody production. 118, 119 Earlier studies showed that chronic intestinal inflammation induces the upregulation of CD1d expression on B cells in the MLN and LP, leading to enhanced IL-10 production that can suppress the progression of intestinal inflammation. 120 These studies identified a specific regulatory role for CD1d-expressing B cells within the intestinal tissues.
A recent study showed that conventional IEL preparations contain a specific subset of B cells that resides in the superficial LP (SLP) of the small and large intestine. 121 The formation of SLP B cells in the small intestinal villi was completely dependent on lymphotoxin-and, partially, on proper BCR signaling. Interestingly, these B cells were not dependent on the resident microbiota or innate microbial sensing, but were specifically reduced in the small intestine of iNKT cell-deficient mice. As it was found that SLP B cells and iNKT cells are fully preserved in germ-free mice, 121, 122 B cell -NKT cell interaction may be dependent on food antigens or endogenous glycolipids, rather than on commensal microbial antigens. However, additional studies are required to understand the relationship between this special subset of B cells in the small intestinal villi and NKT cells.
REVIEW
Regulation of bacterial colonization by CD1d-restricted NKT cells
CD1d-restricted NKT cells have been shown to be involved in the host defense against various bacterial, fungal, and viral pathogens, including those that reside in the lung and intestine. 5, 67 Although the exact ligands involved in this antimicrobial NKT cell activation are not yet identified, they may include both pathogenic and host-derived glycolipids that are induced by the microbiota. 54, 55, 59 Most of the bacteria residing within the intestinal lumen are located in the colon, whereas colonization of the small intestine remains limited, suggesting the existence of potent local regulatory mechanisms. The current understanding of how bacterial commensalism is established in mammals and which host factors contribute to this process is relatively unknown. 123 Bacteria can interact with the host at a cellular level through contact with IEC and hematopoietic cells, which are associated with innate and adaptive immune responses. 124 For example, B cells can respond to bacterial products by the production of bacteria-specific antibodies (mainly IgA), thus disabling bacterial translocation across the epithelial cell layers. 124, 125 IECs can regulate homeostasis by responding to bacterial-derived antigens through the expression and activation of microbial pattern recognition molecules such as TLRs. 126 Within the small intestine, Paneth cells (Pcs) are located at the bottom of the crypts of Lieberk ü hn. Upon activation, Pcs secrete various antibacterial proteins, such as cryptdins or -defensins, into the intestinal crypts. 127 As Pcs are located mainly in the small intestine, their presence may contribute to the relative low grade of bacterial colonization at that specific segment of the intestinal tract. 128, 129 Previously, Pcs in mice were found to express CD1d, 130 similar to the CD1d expression on IECs 43, 46, 131, 132 and hematopoietic cells. 133 We have recently shown that colonization of the intestine with a range of bacteria ( Pseudomonas aeruginosa , Staphylococcus aureus , non-pathogenic Escherichia coli , and Lactobacillus gasseri ) is regulated by CD1d. 68 CD1d-deficient mice were found to have an altered bacterial composition including increased numbers of adherent bacteria. As a mechanism of action, CD1d-mediated pathways were shown to regulate Pc function. In vitro studies indicated that CD1d expression by IEC and / or Pc was sufficient for NKT cell-mediated Pc granule content release. In addition, other mucosal CD1d-expressing APCs may be involved.
It has been proposed that intestinal NKT cells may regulate Pc function upon recognition of bacteria-derived lipid antigens ( Figure 3 ) , and thus take part in reciprocal interactions between the microbiota and host cells. On the basis of various bacteria that are seemingly regulated by CD1d-restricted mechanisms, it seems more likely that colonization induces a common (endogenous) antigen that is responsible for local NKT activation. 68 This CD1d-restricted pathway may represent an alternative to the previously described TLR-induced Pc activation routes. 127 As such, NKT cells have now been implicated in at least three mechanisms of antimicrobial defense. First, through NKT cell expression and release of antimicrobial mediators by cells, for example, granulysin; 134 second, through activation of innate (e.g., macrophages 67 ) and adaptive immune cells involved in antimicrobial responses; 135 and third, through the regulation of non-myeloid cells such as Pc. 68 Given the function of Pc in the regulation of mucosal homeostasis, we hypothesize that aberrant CD1d -NKT cell pathways may be involved in the pathogenesis of IBD. Along similar lines, it has been shown that polymorphisms within the genes NOD2 / CARD15, ATG16L1, or XBP-1 are associated with IBD. 136 -139 In all of these cases, the described mutations lead to Pc dysfunction and impaired microbial clearance. It has been suggested that in these conditions, overt microbial translocation will give rise to excessive mucosal immune responses that are key to the IBD pathogenesis. Similarly, inadequate or dysregulated CD1d-restricted NKT cell regulation of Pc could contribute to the development of entero-colitis ( Figure 3 and ref. 68) .
CONCLUDING REMARKS
Currently, many studies focus on the discovery of novel NKT cell ligands from microorganisms and antigens that are derived from endogenous sources. Next to the thoroughly studied classical CD1d-restricted iNKT cells, novel (invariant) T-cell subsets with other selecting antigen-presenting molecules have been discovered. This emerging knowledge will contribute to our understanding of the complex interplay between the microbiota and immune cells in homeostatic and inflammatory conditions of the intestinal mucosa.
REFERENCES
.
Bendelac , A . , Savage 
